Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2025-12-24 @ 11:45 PM
NCT ID:
NCT03291951
Eligibility Criteria:
Inclusion Criteria:
* Men and women ≥18 years
* Newly diagnosed with histologically confirmed stage II-Ill colon cancer
* Completed curative-intent surgical resection
* Currently prescribed one of the following adjuvant chemotherapy regimens: (IV 5-fluorouracil \[5-FU\] / leucovorin \[LV\], capecitabine, FOLFOX \[5-FU, LV, oxaliplatin\], CAPOX \[capecitabine and oxaliplatin\]
* Patients must have started chemotherapy or plan to start with receipt of the first exercise visit by 3rd infusion visit. Patients enrolled at the Dana-Farber Cancer Institute and who are receiving FOLFOX chemotherapy are eligible to enroll in the pharmacokinetics sub-study.
* No planned major surgery anticipated in the intervention period
* Sufficient time to heal from any major surgery to start of intervention, including colostomy reversal (port-a-cath removal excluded)
* Approval by either oncologist or surgeon to participate in trial
* Readiness as determined by the Physical Activity Readiness Questionnaire
* Ability to understand and the willingness to sign a written informed consent document in English
* Willingness to be randomized
Exclusion Criteria:
* Concurrent actively treated other cancer (except non-melanoma skin cancer, in situ cervical cancer or localized prostate cancer treated with surveillance only)
* Patients with untreated hypertension (\>180 mm Hg systolic or \>100 mm Hg diastolic) appearing in the patient's medical record in the two weeks prior to screening
* Presence of metastatic disease
* Current strength training \>2x week for the past 3 or more months
* Patients enrolled in other clinical trials of weight loss, physical activity or dietary interventions are ineligible.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03291951
Study Brief:
Protocol Section:
NCT03291951